457985AM1

Integra Lifesciences Holdings Corp

Could not find a ticker for this position, may be a filing error

A maker of surgical and medical devices used by neurosurgeons, reconstructive surgeons, and general surgeons. Its best-known product is the Integra Dermal Regeneration Template, a bioengineered "artificial skin" scaffold that helps severe burn victims grow new skin. The company was founded in 1989 by Dr. Richard Caruso, who licensed the collagen-scaffold technology developed at MIT and Harvard. Its name reflects the product's purpose: the matrix integrates with the patient's own body to regenerate tissue.

CONVERTIBLEUnderlying: IARTCUSIP: 457985AM1HealthcareUS1 derivative reporter

0.50% Convertible Senior Notes due August 15, 2025

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 6 months

Hill Barbara BDirector · 2 transactions

187.5K+14.9%

Granted 24.3K

Bradley KeithDirector · 1 transaction

88.3K-1%

Davis Robert T. Jr.EVP & President, TT · 2 transactions

66.4K+3.7%

McBreen Michael J.EVP & President, CSS · 2 transactions

60.7K-13.6%

Knight Lea DanielsEVP & Chief Financial Officer · 1 transaction

50.5K-13.8%

Singh HarvinderEVP & PRESIDENT, INTERNATIONAL · 5 transactions

40.6K+61.1%

Granted 20.1K

Mosebrook JeffreySVP, Fin & Princ Acct Officer · 2 transactions

35.5K-3.1%

Veillon-Berteloot ChantalEVP & CHRO · 1 transaction

22.2K-23.5%

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Hill Barbara BDirector · 2 transactions	+14.9%	187.5K	24.3K	—	—
Bradley KeithDirector · 1 transaction	-1%	88.3K	—	—	—
Davis Robert T. Jr.EVP & President, TT · 2 transactions	+3.7%	66.4K	—	—	—
McBreen Michael J.EVP & President, CSS · 2 transactions	-13.6%	60.7K	—	—	—
Knight Lea DanielsEVP & Chief Financial Officer · 1 transaction	-13.8%	50.5K	—	—	—
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL · 5 transactions	+61.1%	40.6K	20.1K	—	—
Mosebrook JeffreySVP, Fin & Princ Acct Officer · 2 transactions	-3.1%	35.5K	—	—	—
Veillon-Berteloot ChantalEVP & CHRO · 1 transaction	-23.5%	22.2K	—	—	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.